Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Synthetic” and “natural” are largely useless terms. But not “semisynthetic.” It’s a real word that describes a critical ...

Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...

Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

Regulatory approval is a major milestone in the drug development process, but it is not the final chapter in the journey.

Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report ...